GE Healthcare has a strong stake in molecular imaging, but Jean-Luc Vanderheyden, Ph.D., global molecular imaging leader, technology and medical office, noted that molecular imaging means different things to different people. “We got our start in molecular imaging as applied to drug development, but imaging is a rapidly expanding and inclusive field.”
At the congress, the company presented a full range of solid-state imaging technologies—the ability to see the entire animal—“which may well become the standard for small-animal study,” said Dr. Vanderheyden.
GE’s eXplore speCZT is a full-ring solid-state detector small-animal SPECT that focuses on high throughput and rapid dynamic imaging. It uses a cadmium zinc telluride (CZT) detector, allowing for full 360º coverage around the animal and high-energy resolution to enable dual or triple radio-nuclide imaging. The increased sensitivity of speCZT helps medical researchers perform dynamic small-animal SPECT imaging to precisely quantify radio-tracer uptake and identify morphological changes, Dr. Vanderheyden said.
“The technology from this small-animal SPECT was used to help create advances in nuclear cardiology patients,” he added. “Imaging has been part of preclinical studies for decades, but the movement toward noninvasive imagery is quite new. The convergence of technologies, provide researchers the materials and knowledge they need to do their jobs.”